Optimizing Collimator Margins for Isotoxically Dose-Escalated Conformal Radiation Therapy of Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Optimizing Collimator Margins for Isotoxically Dose-Escalated Conformal Radiation Therapy of Non-Small Cell Lung Cancer

Published:2014-04 Issue:5 Volume:88 Page:1148-1153
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Warren Samantha,Panettieri Vanessa,Panakis Niki,Bates Nicholas,Lester Jason F.,Jain Pooja,Landau David B.,Nahum Alan E.,Mayles W. Philip M.,Fenwick John D.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference21 articles.

1. Non-small cell lung cancer in stages I-IIIB: Long-term results of definitive radiation otherapy with doses ≥80 Gy in standard fractionation;Wurstbauer;Strahlenther Onkol,2010

2. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer;van Baardwijk;J Clin Oncol,2010

3. Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: A prospective population-based study;De Ruysscher;Radiother Oncol,2012

4. Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117;Bradley;J Clin Oncol,2010

5. Are the results of RTOG 0617 mysterious?;Cox;Int J Radiat Oncol Biol Phys,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Planning target volume density impact on treatment planning for lung stereotactic body radiation therapy;Acta Oncologica;2021-07-14

2. Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans;The British Journal of Radiology;2019-02

3. The potential for increased tumor control probability in non–small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume;Medical Dosimetry;2018

4. Magnetic resonance imaging in precision radiation therapy for lung cancer;Translational Lung Cancer Research;2017-12

5. Normal tissue considerations and dose–volume constraints in the moderately hypofractionated treatment of non-small cell lung cancer;Radiotherapy and Oncology;2016-06